Infectious Diseases Trial of a Long-Acting Malaria Drug Injection Launches in RwandaGlobal Biodefense StaffNovember 5, 2026
CBRNE Radiation Countermeasure Entolimod Clears Mouse Safety Study, Moves to Survival TestGlobal Biodefense StaffNovember 3, 2026
Medical Countermeasures UK Commits £33.2 Million to Eight Vaccine Projects Targeting Ebola, Marburg, Plague and Other Epidemic ThreatsGlobal Biodefense StaffOctober 18, 2026
DTRA to Advance Nanostructured Therapeutics for Chem-Bio Defense Contracts + Grants October 22, 2012 …
BARDA Exercises Contract Option on Emergent BioSolutions Anthrax Vaccine Contracts + Grants October 15, 2012 …
NIH Awards $1.8M to Develop Multi-Component Malaria Vaccine Solution Industry News October 13, 2012 …
AstraZeneca and Broad Institute Partner To Advance Antibacterials and Antivirals Antimicrobial Resistance September 17, 2012 …
FDA Grants Priority Review for Multi-Drug Resistant Tuberculosis Treatment Medical Countermeasures September 6, 2012 …